Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 5 studies | 30% ± 9% | |
endothelial cell | 3 studies | 21% ± 3% |
Insufficient scRNA-seq data for expression of PAQR5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 4315.82 | 89 / 89 | 96% | 19.66 | 866 / 901 |
pancreas | 100% | 538.85 | 328 / 328 | 72% | 4.76 | 128 / 178 |
lung | 99% | 933.56 | 575 / 578 | 65% | 4.01 | 754 / 1155 |
stomach | 82% | 704.67 | 296 / 359 | 69% | 5.59 | 196 / 286 |
intestine | 62% | 965.14 | 600 / 966 | 84% | 6.79 | 445 / 527 |
adrenal gland | 100% | 3034.91 | 258 / 258 | 32% | 3.91 | 74 / 230 |
esophagus | 57% | 562.71 | 827 / 1445 | 73% | 5.57 | 134 / 183 |
skin | 99% | 616.94 | 1782 / 1809 | 25% | 1.13 | 116 / 472 |
bladder | 67% | 247.29 | 14 / 21 | 52% | 3.92 | 260 / 504 |
breast | 43% | 97.20 | 199 / 459 | 61% | 4.16 | 683 / 1118 |
uterus | 53% | 176.74 | 90 / 170 | 47% | 3.21 | 215 / 459 |
brain | 84% | 199.60 | 2222 / 2642 | 10% | 0.28 | 74 / 705 |
liver | 29% | 56.27 | 66 / 226 | 51% | 6.92 | 206 / 406 |
prostate | 60% | 115.36 | 148 / 245 | 1% | 0.05 | 7 / 502 |
thymus | 54% | 86.87 | 350 / 653 | 8% | 0.72 | 48 / 605 |
blood vessel | 59% | 132.46 | 784 / 1335 | 0% | 0 | 0 / 0 |
ovary | 25% | 46.16 | 45 / 180 | 23% | 1.11 | 99 / 430 |
adipose | 39% | 91.15 | 472 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 38% | 2.56 | 17 / 45 |
eye | 0% | 0 | 0 / 0 | 28% | 0.79 | 22 / 80 |
heart | 25% | 40.62 | 216 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 4.86 | 31 / 929 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.16 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048477 | Biological process | oogenesis |
GO_0005886 | Cellular component | plasma membrane |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0005496 | Molecular function | steroid binding |
Gene name | PAQR5 |
Protein name | Membrane progestin receptor gamma (mPR gamma) (Membrane progesterone P4 receptor gamma) (Membrane progesterone receptor gamma) (Progesterone and adipoQ receptor family member 5) (Progestin and adipoQ receptor family member 5) (Progestin and adipoQ receptor family member V) Progestin and adipoQ receptor family member 5 Alternative protein PAQR5 |
Synonyms | MPRG |
Description | FUNCTION: Plasma membrane progesterone (P4) receptor coupled to G proteins . Seems to act through a G(i) mediated pathway . May be involved in oocyte maturation . . |
Accessions | L8E9R0 ENST00000561153.5 ENST00000395407.7 H0YL06 Q9NXK6 ENST00000558684.5 ENST00000340965.4 |